NL8620486A - Transdermale afgifte van geneesmiddelen. - Google Patents

Transdermale afgifte van geneesmiddelen. Download PDF

Info

Publication number
NL8620486A
NL8620486A NL8620486A NL8620486A NL8620486A NL 8620486 A NL8620486 A NL 8620486A NL 8620486 A NL8620486 A NL 8620486A NL 8620486 A NL8620486 A NL 8620486A NL 8620486 A NL8620486 A NL 8620486A
Authority
NL
Netherlands
Prior art keywords
integer
value
skin
formula
preparation
Prior art date
Application number
NL8620486A
Other languages
English (en)
Dutch (nl)
Original Assignee
Hsieh Dean
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hsieh Dean filed Critical Hsieh Dean
Publication of NL8620486A publication Critical patent/NL8620486A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8620486A 1985-12-04 1986-11-28 Transdermale afgifte van geneesmiddelen. NL8620486A (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US80466185A 1985-12-04 1985-12-04
US80466185 1985-12-04
US89904986A 1986-08-21 1986-08-21
US89904986 1986-08-21
US8602583 1986-11-28
PCT/US1986/002583 WO1987003473A1 (en) 1985-12-04 1986-11-28 Transdermal delivery of drugs

Publications (1)

Publication Number Publication Date
NL8620486A true NL8620486A (nl) 1987-11-02

Family

ID=27122711

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8620486A NL8620486A (nl) 1985-12-04 1986-11-28 Transdermale afgifte van geneesmiddelen.

Country Status (14)

Country Link
EP (1) EP0248885B1 (xx)
JP (1) JP2583777B2 (xx)
KR (1) KR940011209B1 (xx)
AU (1) AU6738487A (xx)
CA (1) CA1312281C (xx)
CH (1) CH666813A5 (xx)
DE (2) DE3690626C2 (xx)
DK (1) DK167343B1 (xx)
FI (1) FI873328A (xx)
GB (1) GB2192134B (xx)
LU (1) LU91289I2 (xx)
NL (1) NL8620486A (xx)
SE (1) SE8703032L (xx)
WO (1) WO1987003473A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
USRE36744E (en) * 1988-09-16 2000-06-20 Ribogene, Inc. Nasal administration of benzodiazepine hypnotics
JPH02104531A (ja) * 1988-10-14 1990-04-17 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド組成物
US5278142A (en) * 1989-03-20 1994-01-11 Orbon Corporation Systemic delivery of polypeptides through the eye
US5182258A (en) * 1989-03-20 1993-01-26 Orbon Corporation Systemic delivery of polypeptides through the eye
CA2110040A1 (en) * 1991-05-31 1992-12-10 Lyle J. Arnold, Jr. Compositions and delivery systems for transdermal administration of neutral oligomers
US5858398A (en) * 1994-11-03 1999-01-12 Isomed Inc. Microparticular pharmaceutical compositions
CA2275971C (en) * 1997-01-09 2008-04-29 Conrex Pharmaceutical Corporation Composition for enhancing skin or hair
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
CA2451839C (en) * 2001-06-22 2013-08-06 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions comprising peptides and permeation enhancers
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
JP4558363B2 (ja) * 2003-06-19 2010-10-06 日本メナード化粧品株式会社 香料組成物
ES2348303T3 (es) * 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Composiciones farmacauticas y procedimientos de tratamiento con insulina.
JP2008506767A (ja) * 2004-07-19 2008-03-06 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 発毛を刺激する製剤
DK1937276T3 (da) 2005-10-12 2013-02-11 Besins Healthcare Luxembourg Forbedret testosterongel og fremgangsmåde til anvendelse deraf
EP1905454A1 (en) * 2006-09-27 2008-04-02 Paolo Botti Formulations comprising cyclic compounds
PL4104848T3 (pl) 2009-06-18 2024-03-25 Acerus Pharmaceuticals USA, LLC Bezpieczne podawanie desmopresyny

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3716823A (en) * 1960-12-15 1973-02-13 Us Navy Polychromatic sonar object identification system
US3474176A (en) * 1965-12-06 1969-10-21 Int Flavors & Fragrances Inc Repelling animals with ketone
US3964482A (en) * 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
FR2463938B1 (fr) * 1979-08-23 1985-07-26 Labo Cent Telecommunicat Radar doppler pour detecter et localiser les helicopteres
JPS57161572A (en) * 1981-03-31 1982-10-05 Tech Res & Dev Inst Of Japan Def Agency Discriminating device to ground
US4590190A (en) * 1983-07-01 1986-05-20 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent

Also Published As

Publication number Publication date
DK403187A (da) 1987-08-03
KR880700661A (ko) 1988-04-11
LU91289I2 (fr) 2006-11-21
EP0248885A4 (en) 1988-05-16
SE8703032L (sv) 1987-08-03
GB2192134B (en) 1990-04-25
JPS63501954A (ja) 1988-08-04
SE8703032D0 (xx) 1987-08-03
FI873328A0 (fi) 1987-07-30
DK403187D0 (da) 1987-08-03
WO1987003473A1 (en) 1987-06-18
DE3690626C2 (de) 1997-05-15
EP0248885B1 (en) 1992-08-05
CA1312281C (en) 1993-01-05
DE3690626T (xx) 1988-01-28
JP2583777B2 (ja) 1997-02-19
GB8718404D0 (en) 1987-09-09
GB2192134A (en) 1988-01-06
DK167343B1 (da) 1993-10-18
AU6738487A (en) 1987-06-30
KR940011209B1 (ko) 1994-11-29
FI873328A (fi) 1987-07-30
EP0248885A1 (en) 1987-12-16
CH666813A5 (de) 1988-08-31

Similar Documents

Publication Publication Date Title
US5731303A (en) Transdermal and trans-membrane delivery compositions
NL8620486A (nl) Transdermale afgifte van geneesmiddelen.
US5023252A (en) Transdermal and trans-membrane delivery of drugs
EP1674068B1 (en) Dermal penetration enhancers and drug delivery systems involving same
Stoughton et al. Azone®: a new non-toxic enhancer of cu'taneous penetration
RU2117490C1 (ru) Трансдермальная композиция для местного введения терапевтически и/или профилактически активного агента, лента или повязки для трансдермальной доставки
EP1741433B1 (en) Pharmaceutical composition comprising an androgen
CA2135598A1 (en) Anhydrous formulations for administering lipophilic agents
NL8403618A (nl) Werkwijze voor het percutaan toedienen van metoclopramide.
JPH11513393A (ja) 皮膚又は粘膜表面へのもしくは介する活性物質の投与用医薬組成物
AU5906686A (en) Pharmaceutical vehicles for reducing transdermal flux
US6916486B2 (en) Transdermal delivery of analgesics
US6455586B1 (en) Topical immunomodulating compositions for treatment of aids, Hepatitis B & C, other infectious diseases, and cancer
JP3207212B2 (ja) 吸収促進剤およびこれを含有する外用剤
JPH0672108B2 (ja) 水素化ひまし油を含む長期持続性注射製剤
Setty et al. Effect of essential oils as penetration enhancers on percutaneous penetration of furosemide through human cadaver skin
RU2618462C2 (ru) Способ и улучшенная фармацевтическая композиция для ускорения трансдермальной доставки ингибитора pde-5
RU2140737C1 (ru) Средство для профилактики и лечения паразитарных заболеваний животных
NO873145L (no) Transdermal avlevering av legemidler.
US5183665A (en) Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
JPH0759519B2 (ja) 経皮吸収促進剤及びこれを含有する皮膚外用製剤
WO1990008553A1 (en) Transdermal drug delivery composition
JPS62187415A (ja) 経皮吸収促進用組成物
JPH08104621A (ja) ガム型徐放製剤
UA63137C2 (en) Foridon gel, drug for treatment and prevention of cardiovascular diseases